welcome
markets.businessinsider.com

markets.businessinsider.com

Health

Health

Stock of the Day: Gilead Sciences falls on report the Trump administration could slash funds for HIV prevention

markets.businessinsider.com
Summary
Nutrition label

72% Informative

Federal funding for HIV prevention could be slashed, according to The Wall Street Journal .

Gilead Sciences fell 2.52% in premarket trading, falling to $ 107.45 per share.

The biopharmaceutical company is up 19.34% for the year .

The company makes medication for treating HIV and AIDS, including treatments for adults with HIV.

VR Score

67

Informative language

62

Neutral language

82

Article tone

formal

Language

English

Language complexity

45

Offensive language

likely offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.